Soleno Therapeutics (SLNO) Enterprise Value Growth (1y) (2014 - 2026)
Soleno Therapeutics (SLNO) Enterprise Value Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.85% |
| Dec 31, 2025 | -4.82% |
| Sep 30, 2025 | -94.32% |
| Jun 30, 2025 | -7.80% |
| Mar 31, 2025 | -93.80% |
| Dec 31, 2024 | -71.76% |
| Sep 30, 2024 | -390.03% |
| Jun 30, 2024 | -1,271.65% |
| Mar 31, 2024 | -1,793.67% |
| Dec 31, 2023 | -1,062.04% |
| Sep 30, 2023 | -165.30% |
| Jun 30, 2023 | 19.50% |
| Mar 31, 2023 | 72.73% |
| Dec 31, 2022 | 31.46% |
| Sep 30, 2022 | 29.92% |
| Jun 30, 2022 | 28.27% |
| Mar 31, 2022 | 30.36% |
| Dec 31, 2021 | 56.72% |
| Sep 30, 2021 | 49.79% |
| Jun 30, 2021 | 46.25% |